Mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia: A report from the italian AIEOP study group

Silvia Bresolin, Paola De Filippi, Francesca Vendemini, Mirko D'Alia, Marco Zecca, Lueder H. Meyer, Cesare Danesino, Franco Locatelli, Riccardo Masetti, Giuseppe Basso, Geertruy te Kronnie

Research output: Contribution to journalArticle

Abstract

Juvenile myelomonocytic leukemia (JMML) is a rare aggressive disease of early childhood. Driver mutations in the Ras signaling pathways are a key feature of JMML patients. Mutations in SETBP1 and JAK3 were recently identified in a subset of JMML patients characterized by poor prognosis and progression of disease. In this study, we report the results of a screening for mutations in SETBP1 and JAK3 of a cohort of seventy Italian patients with JMML, identifying 11.4% of them harboring secondary mutations in these two genes and discovering two new mutations in the SKI domain of SETBP1.JMML xenotransplantation and colony assay provide an initial understanding of the secondary nature of these events occurring in early precursor cells and suggest a different propagating capacity of clones harboring particular mutations.

Original languageEnglish
Pages (from-to)28914-28919
Number of pages6
JournalOncotarget
Volume7
Issue number20
DOIs
Publication statusPublished - May 17 2016

    Fingerprint

Keywords

  • JAK3
  • JMML
  • Murine model
  • SETBP1

ASJC Scopus subject areas

  • Oncology

Cite this

Bresolin, S., De Filippi, P., Vendemini, F., D'Alia, M., Zecca, M., Meyer, L. H., Danesino, C., Locatelli, F., Masetti, R., Basso, G., & te Kronnie, G. (2016). Mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia: A report from the italian AIEOP study group. Oncotarget, 7(20), 28914-28919. https://doi.org/10.18632/oncotarget.8016